Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Guggenheim Securities' Vamil Divan breaks down Merck's stock drop
03:10pm, Tuesday, 04'th Feb 2025
Vamil Divan, Guggenheim Securities biopharmaceutical analyst, joins 'Power Lunch' to discuss Merck's troubles in China.
Merck: Ideal Case Of Why I Love Option Collars (Upgrade To Buy)
02:59pm, Tuesday, 04'th Feb 2025
Merck's current high-risk profile led me to initially rate it a strong sell, but recent technical indicators suggested a potential bottom near $100. I've upgraded MRK to a buy, using a "Dog Collar" st
Why Merck Stock Is Plummeting Today
02:44pm, Tuesday, 04'th Feb 2025
Shares of Merck (MRK -9.66%) were trading lower on Tuesday. The company's stock had lost 10.1% as of 2 p.m.
Big Pharma, Bigger Bargain: Why Merck Stock Is Too Cheap To Ignore (Upgrade)
02:44pm, Tuesday, 04'th Feb 2025
Healthcare costs are rising, with PwC projecting the highest commercial healthcare spending growth in 13 years, impacting consumers and insurance companies negatively. Healthcare stocks, including Mer
Merck & Co., Inc. (MRK) Q4 2024 Earnings Call Transcript
12:55pm, Tuesday, 04'th Feb 2025
Merck & Co., Inc. (NYSE:MRK ) Q4 2024 Results Conference Call February 4, 2025 9:00 AM ET Company Participants Peter Dannenbaum - Senior Vice President, Investor Relations Rob Davis - Chairman and Chi
Merck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 View
12:35pm, Tuesday, 04'th Feb 2025
MRK posts encouraging Q4 results. However, the decision to temporarily halt shipments of Gardasil vaccines to China has affected its 2025 sales forecast.
Merck shares plunge on weak 2025 outlook, pause in Gardasil shipments to China
11:58am, Tuesday, 04'th Feb 2025
Merck & Co Inc (NYSE:MRK, ETR:6MK) shares fell more than 10% after the drugmaker issued weak guidance for 2025 and announced it would halt shipments of its HPV vaccine Gardasil to China until at least
Merck (MRK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Tuesday, 04'th Feb 2025
Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street
Merck Stock Slumps as Q4 Profits, 2025 Forecast Fall Short
10:08am, Tuesday, 04'th Feb 2025
Merck shares tumbled Tuesday morning after the drugmaker's soft outlook outweighed fourth-quarter revenue that topped expectations.
2 Blue-Chip Drug Stocks in Focus Today After Earnings
10:06am, Tuesday, 04'th Feb 2025
Stocks are struggling for direction today, and one sector that represents this choppiness is blue-chip drugmakers.
Merck (MRK) Tops Q4 Earnings and Revenue Estimates
08:41am, Tuesday, 04'th Feb 2025
Merck (MRK) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $0.03 per share a year ago.
Mizuho's Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
08:35am, Tuesday, 04'th Feb 2025
Jared Holz, Mizuho Securities America healthcare sector strategist, joins 'Squawk Box' to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and mor
Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook
08:34am, Tuesday, 04'th Feb 2025
On Tuesday, Merck & Co Inc MRK reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of foreign
Merck's soft guidance overshadows quarterly beat to send stock down 6%
07:17am, Tuesday, 04'th Feb 2025
Merck's stock tumbled 6% early Tuesday, after the drug company's softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
06:33am, Tuesday, 04'th Feb 2025
Merck on issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil, a vaccine that preve
